Distinction of intrahepatic metastasis from multi centric carcinogenesis in multifocal hepatocellular carcinoma using molecular alterations

被引:22
作者
Chianchiano, Peter [1 ]
Pezhouh, Maryam Kherad [1 ]
Kim, Amy [2 ]
Luchini, Claudio [3 ]
Cameron, Andrew [4 ]
Weiss, Matthew J. [4 ]
He, Jin [4 ]
Voltaggio, Lysandra [1 ]
Oshima, Kiyoko [1 ]
Anders, Robert A. [1 ]
Wood, Laura D. [1 ,5 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21231 USA
[3] Univ Verona, Sect Pathol, Dept Diagnost & Publ Hlth, I-37134 Verona, Italy
[4] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21231 USA
[5] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
基金
美国国家卫生研究院;
关键词
Multifocal hepatocellular carcinoma; Multicentric carcinogenesis; Intrahepatic metastasis; Sanger sequencing; Next-generation sequencing; CLONAL ORIGIN; SOMATIC MUTATIONS; RECURRENCE; RESECTION; PROMOTER; TUMORS;
D O I
10.1016/j.humpath.2017.11.011
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Patients with hepatocellular carcinoma (HCC) frequently have multiple anatomically distinct tumors. In these patients, multifocal HCC could represent intrahepatic metastases (IMs) of a single cancer or multidentric carcinogenesis (MC) with multiple independent neoplasms. To determine the frequency and clinical implications of these 2 possibilities, we performed histological and molecular analysis of 70 anatomically distinct HCCs from 24 patients. We assayed mutations in the TERT promoter region by Sanger sequencing and used next-generation sequencing to analyze the entire coding regions of 7 well-characterized HCC driver genes based on shared or discordant mutations in these genes, we classified the HCCs in each patient as IM, MC, or indeterminate. Mutations in the TERT promoter were the most common alteration in our cohort, present in 71% of tumors analyzed. Mutations in the remaining genes occurred in less than 20% of analyzed tumors. We were able to determine the relatedness in 58% of the patients analyzed: MC occurred in 41% of patients, with 33% with exclusively MC and 8% with both MC and IM. IM occurred exclusively in 17% of patients, whereas the remainder were indeterminate. This study highlights the utility of molecular analyses to determine relatedness in multifocal HCC; however, targeted sequencing can only resolve this distinction in approximately 60% of patients with multifocal HCC. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:127 / 134
页数:8
相关论文
共 24 条
  • [1] Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
    Ally, Adrian
    Balasundaram, Miruna
    Carlsen, Rebecca
    Chuah, Eric
    Clarke, Amanda
    Dhalla, Noreen
    Holt, Robert A.
    Jones, Steven J. M.
    Lee, Darlene
    Ma, Yussanne
    Marra, Marco A.
    Mayo, Michael
    Moore, Richard A.
    Mungall, Andrew J.
    Schein, Jacqueline E.
    Sipahimalani, Payal
    Tam, Angela
    Thiessen, Nina
    Cheung, Dorothy
    Wong, Tina
    Brooks, Denise
    Robertson, A. Gordon
    Bowlby, Reanne
    Mungall, Karen
    Sadeghi, Sara
    Xi, Liu
    Covington, Kyle
    Shinbrot, Eve
    Wheeler, David A.
    Gibbs, Richard A.
    Donehower, Lawrence A.
    Wang, Linghua
    Bowen, Jay
    Gastier-Foster, Julie M.
    Gerken, Mark
    Helsel, Carmen
    Leraas, Kristen M.
    Lichtenberg, Tara M.
    Ramirez, Nilsa C.
    Wise, Lisa
    Zmuda, Erik
    Gabriel, Stacey B.
    Meyerson, Matthew
    Cibulskis, Carrie
    Murray, Bradley A.
    Shih, Juliann
    Beroukhim, Rameen
    Cherniack, Andrew D.
    Schumacher, Steven E.
    Saksena, Gordon
    [J]. CELL, 2017, 169 (07) : 1327 - +
  • [2] Treatment and Prognosis of Hepatocellular Carcinoma: A Population Based Study in France
    Borie, Frederic
    Bouvier, Anne-Marie
    Herrero, Astrid
    Faivre, Jean
    Launoy, Guy
    Delafosse, Patricia
    Velten, Michel
    Buemi, Antoine
    Peng, Jun
    Grosclaude, Pascale
    Tretarre, Brigitte
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (07) : 505 - 509
  • [3] Identification of Driver Genes in Hepatocellular Carcinoma by Exome Sequencing
    Cleary, Sean P.
    Jeck, William R.
    Zhao, Xiaobei
    Chen, Kui
    Selitsky, Sara R.
    Savich, Gleb L.
    Tan, Ting-Xu
    Wu, Michael C.
    Getz, Gad
    Lawrence, Michael S.
    Parker, Joel S.
    Li, Jinyu
    Powers, Scott
    Kim, Hyeja
    Fischer, Sandra
    Guindi, Maha
    Ghanekar, Anand
    Chiang, Derek Y.
    [J]. HEPATOLOGY, 2013, 58 (05) : 1693 - 1702
  • [4] Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
    Guichard, Cecile
    Amaddeo, Giuliana
    Imbeaud, Sandrine
    Ladeiro, Yannick
    Pelletier, Laura
    Ben Maad, Ichrafe
    Calderaro, Julien
    Bioulac-Sage, Paulette
    Letexier, Melanie
    Degos, Francoise
    Clement, Bruno
    Balabaud, Charles
    Chevet, Eric
    Laurent, Alexis
    Couchy, Gabrielle
    Letouze, Eric
    Calvo, Fabien
    Zucman-Rossi, Jessica
    [J]. NATURE GENETICS, 2012, 44 (06) : 694 - U120
  • [5] Clonal Origin of Multifocal Hepatocellular Carcinoma
    Hodges, Kurt B.
    Cummings, Oscar W.
    Saxena, Romil
    Wang, Mingsheng
    Zhang, Shaobo
    Lopez-Beltran, Antonio
    Montironi, Rodolfo
    Nour, Hammam
    Cheng, Liang
    [J]. CANCER, 2010, 116 (17) : 4078 - 4085
  • [6] IKEDA K, 1993, CANCER, V71, P19, DOI 10.1002/1097-0142(19930101)71:1<19::AID-CNCR2820710105>3.0.CO
  • [7] 2-I
  • [8] Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms
    Jiang, Weiqin
    Ding, Yongfeng
    Shen, Yifei
    Fan, Longjiang
    Zhou, Linfu
    Li, Zhi
    Zheng, Yi
    Zhao, Peng
    Liu, Lulu
    Tong, Zhou
    Fang, Weijia
    Wang, Weilin
    [J]. ONCOTARGET, 2017, 8 (03) : 5016 - 5025
  • [9] TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
    Killela, Patrick J.
    Reitman, Zachary J.
    Jiao, Yuchen
    Bettegowda, Chetan
    Agrawal, Nishant
    Diaz, Luis A., Jr.
    Friedman, Allan H.
    Friedman, Henry
    Gallia, Gary L.
    Giovanella, Beppino C.
    Grollman, Arthur P.
    He, Tong-Chuan
    He, Yiping
    Hruban, Ralph H.
    Jallo, George I.
    Mandahl, Nils
    Meeker, Alan K.
    Mertens, Fredrik
    Netto, George J.
    Rasheed, B. Ahmed
    Riggins, Gregory J.
    Rosenquist, Thomas A.
    Schiffman, Mark
    Shih, Ie-Ming
    Theodorescu, Dan
    Torbenson, Michael S.
    Velculescu, Victor E.
    Wang, Tian-Li
    Wentzensen, Nicolas
    Wood, Laura D.
    Zhang, Ming
    McLendon, Roger E.
    Bigner, Darell D.
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Papadopoulos, Nickolas
    Yan, Hai
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (15) : 6021 - 6026
  • [10] Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
    Li, Meng
    Zhao, Hong
    Zhang, Xiaosong
    Wood, Laura D.
    Anders, Robert A.
    Choti, Michael A.
    Pawlik, Timothy M.
    Daniel, Hubert D.
    Kannangai, Rajesh
    Offerhaus, G. Johan A.
    Velculescu, Victor E.
    Wang, Linfang
    Zhou, Shibin
    Vogelstein, Bert
    Hruban, Ralph H.
    Papadopoulos, Nick
    Cai, Jianqiang
    Torbenson, Michael S.
    Kinzler, Kenneth W.
    [J]. NATURE GENETICS, 2011, 43 (09) : 828 - 829